Kamada Shares Slide After It Raises $51.6 Million in U.S. IPO

The biopharmaceutical company share prices fall on the Tel Aviv Stock Exchange on Sunday.

comments Print
Kamada, a biopharmaceutical company whose unique protein purification technology is used to develop treatments for lung and other diseases, saw its Tel Aviv Stock Exchange share price fall yesterday after it...